Jupiter Pharmaceutical

Founded: 1969 • Age: 57 yrs
Pharmaceutical products and services focused on healthcare solutions in India.
Annual revenue $3.2M Latest available
Total funding - Funding intelligence
Employees 202 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Jupiter Pharmaceutical

Jupiter Pharmaceutical is a company founded in 1969. The company has 202 employees as of April 02, 2024. Jupiter Pharmaceutical offers products and services including CarminoZyme and Glycoseptol.

  • Employees 202 as on 02 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Social
    Locked
  • Legal Name Jupiter Pharmaceuticals Limited
  • Jurisdiction Kolkata, West Bengal, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $3.19 M (USD)
    7.97
    as on Mar 31, 2023
  • Net Profit
    $303.96 K (USD)
    -7.09
    as on Mar 31, 2023
  • EBITDA
    $700.57 K (USD)
    6.37
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    202

    as on Apr 02, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Jupiter Pharmaceutical

Jupiter Pharmaceutical offers a comprehensive portfolio of products and services, including CarminoZyme and Glycoseptol.

Product name locked
Category locked
Primary

This product is utilized for gastro-related health needs, as it has been developed under the company's formulation research efforts.

Product name locked
Category locked
Locked

This product is employed for general health purposes, where it is made available through the company's distribution networks.

Funding Insights of Jupiter Pharmaceutical

Premium access

Detailed funding history for Jupiter Pharmaceutical

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Jupiter Pharmaceutical

Investments
Premium access

Investment portfolio details for Jupiter Pharmaceutical

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Jupiter Pharmaceutical

Premium access

Detailed financials for Jupiter Pharmaceutical

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Jupiter Pharmaceutical Comparisons

Jupiter Pharmaceutical Primary company
Description
Pharmaceutical products and services focused on healthcare s...
Location
-
Founded Year
1969
Annual Revenue
$3.19 M (USD)
Net Profit
$303.96 K (USD)
EBITDA
$700.57 K (USD)
Employees
202
As of 2024
Premium access

Peer comparison for Jupiter Pharmaceutical

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Jupiter Pharmaceutical

Premium access

Detailed competitors of Jupiter Pharmaceutical

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Jupiter Pharmaceutical

Premium access

Complete news archive for Jupiter Pharmaceutical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jupiter Pharmaceutical

Jupiter Pharmaceutical was founded in 1969.

As of Apr 02, 2024, the latest employee count at Jupiter Pharmaceutical is 202.

Annual revenue of Jupiter Pharmaceutical is $3.19M as on Mar 31, 2023.

Jupiter Pharmaceutical has been operated since 1969, with efforts directed towards providing healthcare solutions in areas such as gastro, cough and cold, and general health. Innovation in formulations is pursued through thorough investigations by the research team, while quality is maintained via a dedicated Quality Control Unit that monitors documentation and ensures compliance with international standards. Accessibility is achieved through a wide network across various Indian states, aiming to support the quest for healthier living. The companys legacy is built on achievements in healthcare delivery.

Jupiter Pharmaceutical offers CarminoZyme and Glycoseptol.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available